Esben Schjødt Worm

Hospitalsfysiker, PhD Kræftafdelingen, Aarhus University Hospital esbeworm@rm.dk
Research interests

DK: Mit primære fokusområde er behandlingsplanlægning af stråleterapi samt behandling af bevægelser i stereotaktisk stråleterapi for kroppen. 

UK: My primary research fields are treatment planning for radiotherapy and motion management in stereotactic body radiotherapy.

 Workgroups Publications
  • Worm ES, Hansen R, Høyer M, Weber B, Mortensen H, Poulsen PR Uniform versus non-uniform dose prescription for proton stereotactic body radiotherapy of liver tumors investigated by extensive motion-including treatment simulations Phys Med Biol . 2021 Oct 12;66(20) 2021
  • Muurholm CG, Ravkilde T, Skouboe S, Worm E, Hansen R, Høyer M, Keall PJ, Poulsen PR Real-time dose-guidance in radiotherapy: Proof of principle Radiother Oncol . 2021 Nov;164:175-182 2021
  • Ravkilde T, Skouboe S, Hansen R, Worm E, Poulsen PR. First online real-time evaluation of motion-induced 4D dose errors during radiotherapy delivery. Med Phys 2018: 45; 3893-3903. 2018
  • Poulsen PR, Murtaza G, Worm ES, Ravkilde T, O'Brien R, Grau C, Høyer M, Keall P Simulated multileaf collimator tracking for stereotactic liver radiotherapy guided by kilovoltage intrafraction monitoring: Dosimetric gain and target overdose trends Radiother Oncol 2020: 144; 93-100 2020
  • Poulsen PR, Thomsen MS, Hansen R, Worm E, Spejlborg H, Offersen B Fully automated detection of heart irradiation in cine MV images acquired during breast cancer radiotherapy Radiother Oncol 2020: 152; 189-190 2020
  • Nankali S, Worm ES, Hansen R, Weber B, Høyer M, Zirak A, Poulsen PR Geometric and dosimetric comparison of four intrafraction motion adaptation strategies for stereotactic liver radiotherapy Phys Med Biol 2018: 63; 145010 2018
  • Hansen AT, Poulsen PR, Høyer M, Worm ES Isotoxic dose prescription level strategies for stereotactic liver radiotherapy: the price of dose uniformity Acta Oncol 2020: 59: 558-64 2020
  • Skouboe S, Poulsen PR, Muurholm CG, Worm E, Hansen R, Høyer M, Ravkilde T. Simulated real-time dose reconstruction for moving tumors in stereotactic liver radiotherapy. Med Phys 2019: 46; 4738-4748. 2019
  • Worm ES, Høyer M, Hansen R, Larsen LP, Weber B, Grau C, Poulsen PR. A Prospective Cohort Study of Gated Stereotactic Liver Radiation Therapy Using Continuous Internal Electromagnetic Motion Monitoring. Int J Radiat Oncol Biol Phys. 2018 Jun 1;101(2):366-375 2018
  • D. Sloth Møller, M.L. Schmidt, T. Ravkilde, P.R. Poulsen, J. Hansen, E.S. Worm, H.H. Schmidt, M.M. Knap, A. Safwat, H.K. Rose, L. Hoffmann Intra-fractional stability of deep inspiration breath hold during rt for lung and lymphoma cancer. Radiotherapy and Oncology Volume 133, Supplement 1, April 2019, Pages S531-S532 2019
  • Colvill E, Petersen JBB, Hansen R, Worm E, Skouboe S, Høyer M, Poulsen PR. Validation of fast motion-including dose reconstruction for proton scanning therapy in the liver. Phys Med Biol. 63(22):225021 2018
  • Skouboe S, Ravkilde T, Bertholet J, Hansen R, Worm ES, Muurholm CG, Weber B, Høyer M, Poulsen PR. First clinical real-time motion-including tumor dose reconstruction during radiotherapy delivery. Radiother Oncol. 2019 Oct;139:66-71. 2019
  • Bertholet J, Toftegaard J, Hansen R, Worm ES, Wan H, Parikh PJ, Weber B, Høyer M, Poulsen PR. Automatic online and real-time tumour motion monitoring during stereotactic liver treatments on a conventional linac by combined optical and sparse monoscopic imaging with kilovoltage x-rays (COSMIK). Phys Med Biol. 63(5); pp. 055012 2018
  • Zaer H, Glud AN, Schneider BM, Lukacova S, Vang Hansen K, Adler JR, Høyer M, Jensen MB, Hansen R, Hoffmann L, Worm ES, Sørensen JCH, Orlowski D Radionecrosis and cellular changes in small volume stereotactic brain radiosurgery in a porcine model Sci Rep. 2020 Oct 1;10(1):16223 2020
  • Lee YYD, Nguyen DT, Moodie T, O'Brien R, McMaster A, Hickey A, Pritchard N, Poulsen P, Tabaksblat EM, Weber B, Worm E, Pryor D, Chu J, Hardcastle N, Booth J, Gebski V, Wang T, Keall P Study protocol of the LARK (TROG 17.03) clinical trial: a phase II trial investigating the dosimetric impact of Liver Ablative Radiotherapy using Kilovoltage intrafraction monitoring BMC Cancer. 2021 May 3;21(1):494 2021
  • Mortensen HR, Villadsen GE, Worm ES, Weber B Survival and morbidity following stereotactic radiotherapy of hepatocellular carcinoma: a ten-year, single institution experience Scand J Gastroenterol. 2021 Mar;56(3):259-265 2021
  • Zaer H, Fan W, Orlowski D, Glud AN, Jensen MB, Worm ES, Lukacova S, Mikkelsen TW, Fitting LM, Jacobsen LM, Portmann T, Hsieh JY, Noel C, Weidlich G, Chung W, Riley P, Jenkins C, Adler JR Jr, Schneider MB, Sørensen JCH, Stroh A Non-ablative doses of focal ionizing radiation alters function of central neural circuits Brain Stimul. 2022 May-Jun;15(3):586-597 2022
  • Thuehøj AU, Andersen NC, Worm ES, Høyer M, Tabaksblat EM, Weber B, Mortensen HR Clinical outcomes after stereotactic ablative radiotherapy in locally advanced cholangiocarcinoma Acta Oncol. 2022 Feb;61(2):197-201 2022
  • Nankali S, Hansen R, Worm E, Yates ES, Thomsen MS, Offersen B, Poulsen PR Accuracy and potential improvements of surface-guided breast cancer radiotherapy in deep inspiration breath-hold with daily image-guidance Phys Med Biol. 2022 Sep 26;67(19) 2022